References
- BREWSTER, D., HUMPHREY, M. J. and MCLEAVY, M. A., 1981, The systemic bioavailability of buprenorphine by various routes of administration. Journal of Pharmaceutics and Pharmacology, 33, 500–506.
- CONWAY, W. D., SINGHVI, S. M., GIBALDI, M. and BOYES, R. N., 1973, The effect of route of administration on the metabolic fate of terbutaline in the rat. Xenobiotka, 3, 813–821.
- IwAmoTo, K. and KLAASSEN, C. D., 1977, First-pass effect of morphine in rats. Journal of Pharmacology and Experimental Therapeutics, 200, 236–244.
- LUKAS, G., BRINDLE, S. D. and GREENGARD, P., 1971, The route of absorption of intraperitoneally administered compounds. Journal of Pharmacology and Experimental Therapeutics, 178, 562–566. NICKERSON, D. F., TESS, D. A. and TOLER, S. M., 1997, First pass metabolism and biliary recirculation of droloxifene in female Sprague-Dawley rats. Xenobiotka (in press).
- ROWLAND, M. and TOZER, T. N., 1980, Clinical Pharmacokinetics: Concepts and Applications (Philadelphia: Lea & Febiger).
- TANAKA, Y., SEKIGUCHI, M., SAWAMOTO, T., HATA, T., Esumi, Y., SUGAI, S. and NINOMIYA, S., 1994, Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients. European Journal of Drug Metabolism and Pharmacology, 19, 47–58.
- TESS, D. A., COLE, R. 0. and TOLER, S. M., 1995, Sensitive method for the quantitation of droloxifene in plasma and serum by high-performance liquid chromatography employing fluorimetric detection. Journal of Chromatography B, 674, 253–260.
- ZHONG, W. Z., WILLIAMS, M. G., COOK, K. J., VANDEGlESSEN, T. L., Jos, B. W. and Rousco, K. E., 1994, First-pass effect of cis-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidiny1)-cyclohexyl)-benza-mide (U-54494) in rats—a model with multiple cannulas for investigation of gastrointestinal and hepatic metabolism. Pharmaceutical Research, 11, 1524–1529.